.
Google

                       

Caraco Brand 0.25 mg Digoxin Tablets Recalled Lawsuit


due to Size Variability


> Nationwide Recall of All Lots of Digoxin Tablets 0.25mg Due to Size Variability

Lawyers and Settlements Lawsuit News
Home Page >> Possible Cases >> Caraco Brand 0.25 mg Digoxin Tablets Recalled

Caraco Brand 0.25 mg Digoxin Tablets Recalled due to Size Variability

A S Medication Solutions, LLC, a drug repackage company, has announced that all tablets of Caraco brand Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of August, 2011, are being recalled to the consumer level.

The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin. Caraco Pharmaceutical Laboratories, Ltd manufactured the recalled tablets. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Digoxin is a drug product used to treat heart failure and abnormal heart rhythms. It has a narrow therapeutic index and the existence of higher than labeled dose may pose a risk of digoxin toxicity in patients with renal failure.

Digoxin toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and slow heart rate. Death can also result from excessive digoxin intake. A lower than labeled dose may pose a risk of heart failure and abnormal heart rhythms. Consequently, as a precautionary measure, A S Medication Solutions, LLC is recalling these tablets to the consumer level to minimize any potential risk to patients.

Consumers with the products with the following NDC codes that are within expiration should return these products to the place of purchase.

Product Identification

Caraco Digoxin
A-S Medication Solutions, Digoxin 0.25 mg is a scored round biconvex white tablet imprinted with “441”

NDC Numbers:
Digoxin Tablets, USP, 0.25 mg
54569-5758-0 (30-count)

Patients using A-S Medication Solutions, Digoxin tablets, USP, 0.25 mg, who have medical questions should contact their healthcare provider for additional instructions or guidance.

MAY-12-09-30-08: Caraco Brand 0.25 mg Digoxin Tablets Recalled due to Size Variability [FDA: DIGOXIN 0.25 MG TABLETS RECALLED]

Legal Help

If you or a loved one has suffered adverse events from taking this medication, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Related Law Suits

Caraco Brand 0.25 mg Digoxin Tablets Recalled Law Suit and Settlement

UPDATE 1: Caraco Digoxin Recall Law Suit and Settlement

Infant Teething Tablets Containing Belladonna Recalled Law Suit and Settlement

Digoxin Recalled Law Suit and Settlement

Fentanyl Patches Recalled Law Suit and Settlement

ReliOn Insulin Syringes Recalled Law Suit and Settlement

Piperacillin/Tazobactam for Injection Recalled Law Suit and Settlement

Cardiac Arrhythmia Drug Recalled Law Suit and Settlement

Vicks Dayquil Cold & Flu Liquicaps Recalled Law Suit and Settlement

FDA Law Suit and Settlement

See more stories from this source.



Class Action Law Suits

Newsworthy Law Suits
Defective Products Lawsuits
Discrimination Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Insurance Lawsuits
Malpractice Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits


Related Law Articles

is===1
Related Law Questions

Related Law Bulletins

Lawyers! Become an Approved Expert to Answer Questions.
US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree


Practice Area
Zip Code:

Contact a Lawyer Now!







is===1


1.0325 secs